Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
J Control Release ; 107(2): 276-87, 2005 Oct 03.
Artigo em Inglês | MEDLINE | ID: mdl-16054724

RESUMO

An analogous series of cationic lipids (1,2-distearyloxy-N,N-dimethyl-3-aminopropane (DSDMA), 1,2-dioleyloxy-N,N-dimethyl-3-aminopropane (DODMA), 1,2-dilinoleyloxy-N,N-dimethyl-3-aminopropane (DLinDMA) and 1,2-dilinolenyloxy-N,N-dimethyl-3-aminopropane (DLenDMA)) possessing 0, 1, 2 or 3 double bonds per alkyl chain respectively, was synthesized to determine the correlation between lipid saturation, fusogenicity and efficiency of intracellular nucleic acid delivery. 31P-NMR analysis suggests that as saturation increases, from 2 to 0 double bonds, lamellar (L(alpha)) to reversed hexagonal (H(II)) phase transition temperature increases, indicating decreasing fusogenicity. This trend is largely reflected by the efficiency of gene silencing observed in vitro when the lipids are formulated as Stable Nucleic Acid Lipid Particles (SNALPs) encapsulating small inhibitory RNA (siRNA). Uptake experiments suggest that despite their lower gene silencing efficiency, the less fusogenic particles are more readily internalized by cells. Microscopic visualization of fluorescently labelled siRNA uptake was supported by quantitative data acquired using radiolabelled preparations. Since electrostatic binding is a precursor to uptake, the pKa of each cationic lipid was determined. The results support a transfection model in which endosomal release, mediated by fusion with the endosomal membrane, results in cytoplasmic translocation of the nucleic acid payload.


Assuntos
Lipídeos/química , RNA Interferente Pequeno/administração & dosagem , RNA Interferente Pequeno/química , Cátions , Linhagem Celular , Química Farmacêutica , Composição de Medicamentos , Sistemas de Liberação de Medicamentos , Expressão Gênica/efeitos dos fármacos , Inativação Gênica , Humanos , Luciferases/biossíntese , Luciferases/genética , Espectroscopia de Ressonância Magnética , Neurônios/efeitos dos fármacos , RNA Interferente Pequeno/farmacologia , Tolueno , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA